[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2794648B1 - Vaccins adn pour animaux de compagnie et de sport - Google Patents

Vaccins adn pour animaux de compagnie et de sport

Info

Publication number
FR2794648B1
FR2794648B1 FR9907604A FR9907604A FR2794648B1 FR 2794648 B1 FR2794648 B1 FR 2794648B1 FR 9907604 A FR9907604 A FR 9907604A FR 9907604 A FR9907604 A FR 9907604A FR 2794648 B1 FR2794648 B1 FR 2794648B1
Authority
FR
France
Prior art keywords
dna
vaccine
plasmid
nucleotide sequence
cdv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9907604A
Other languages
English (en)
Other versions
FR2794648A1 (fr
Inventor
Laurent Jean Charles Fischer
Le Roux Simona Barzu
Jean Christophe Franc Audonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9907604A priority Critical patent/FR2794648B1/fr
Application filed by Merial SAS filed Critical Merial SAS
Priority to ES00940474T priority patent/ES2362347T3/es
Priority to KR1020017015911A priority patent/KR100768114B1/ko
Priority to NZ515993A priority patent/NZ515993A/en
Priority to CA2375320A priority patent/CA2375320C/fr
Priority to PCT/FR2000/001592 priority patent/WO2000077043A2/fr
Priority to JP2001503899A priority patent/JP2003502345A/ja
Priority to PL352212A priority patent/PL210451B1/pl
Priority to RU2002100211/13A priority patent/RU2283867C2/ru
Priority to AT00940474T priority patent/ATE499947T1/de
Priority to CZ20014392A priority patent/CZ20014392A3/cs
Priority to DK00940474.0T priority patent/DK1185662T3/da
Priority to BRPI0011732-3A priority patent/BR0011732B1/pt
Priority to DE60045685T priority patent/DE60045685D1/de
Priority to AU55405/00A priority patent/AU782154C/en
Priority to EP00940474A priority patent/EP1185662B1/fr
Priority to ARP000102879A priority patent/AR024334A1/es
Publication of FR2794648A1 publication Critical patent/FR2794648A1/fr
Priority to ZA200110052A priority patent/ZA200110052B/xx
Publication of FR2794648B1 publication Critical patent/FR2794648B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9907604A 1999-06-10 1999-06-10 Vaccins adn pour animaux de compagnie et de sport Expired - Lifetime FR2794648B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR9907604A FR2794648B1 (fr) 1999-06-10 1999-06-10 Vaccins adn pour animaux de compagnie et de sport
BRPI0011732-3A BR0011732B1 (pt) 1999-06-10 2000-06-08 Vacinas de dna para animais de companhia e de esporte
KR1020017015911A KR100768114B1 (ko) 1999-06-10 2000-06-08 애완 동물 및 스포츠용 동물을 위한 ｄｎａ 백신
CA2375320A CA2375320C (fr) 1999-06-10 2000-06-08 Vaccins adn pour animaux de compagnie et de sport
PCT/FR2000/001592 WO2000077043A2 (fr) 1999-06-10 2000-06-08 Vaccins adn pour animaux de compagnie et de sport
JP2001503899A JP2003502345A (ja) 1999-06-10 2000-06-08 ペットまたはスポ−ツ用動物のためのｄｎａワクチン
PL352212A PL210451B1 (pl) 1999-06-10 2000-06-08 Szczepionka DNA przeciwko wirusowi nosówki psów (CDV)
RU2002100211/13A RU2283867C2 (ru) 1999-06-10 2000-06-08 Днк-вакцина (варианты) и иммуногенная композиция против чумки собак
DE60045685T DE60045685D1 (de) 1999-06-10 2000-06-08 Dns-impfstoffe für hunde
CZ20014392A CZ20014392A3 (cs) 1999-06-10 2000-06-08 Vakcína AND pro domácí a sportovní zvířata
ES00940474T ES2362347T3 (es) 1999-06-10 2000-06-08 Vacuna de adn para perros.
NZ515993A NZ515993A (en) 1999-06-10 2000-06-08 DNA vaccines for pets and sport animals
AT00940474T ATE499947T1 (de) 1999-06-10 2000-06-08 Dns-impfstoffe für hunde
AU55405/00A AU782154C (en) 1999-06-10 2000-06-08 DNA vaccines for pets and sport animals
EP00940474A EP1185662B1 (fr) 1999-06-10 2000-06-08 Vaccins adn pour les chiens
DK00940474.0T DK1185662T3 (da) 1999-06-10 2000-06-08 DNA-vacciner til hunde
ARP000102879A AR024334A1 (es) 1999-06-10 2000-06-12 Vacunas adn para animales de compania y de deporte
ZA200110052A ZA200110052B (en) 1999-06-10 2001-12-06 DNA vaccines for pets and sport animals.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907604A FR2794648B1 (fr) 1999-06-10 1999-06-10 Vaccins adn pour animaux de compagnie et de sport

Publications (2)

Publication Number Publication Date
FR2794648A1 FR2794648A1 (fr) 2000-12-15
FR2794648B1 true FR2794648B1 (fr) 2003-03-07

Family

ID=9546856

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9907604A Expired - Lifetime FR2794648B1 (fr) 1999-06-10 1999-06-10 Vaccins adn pour animaux de compagnie et de sport

Country Status (7)

Country Link
AT (1) ATE499947T1 (fr)
DE (1) DE60045685D1 (fr)
DK (1) DK1185662T3 (fr)
ES (1) ES2362347T3 (fr)
FR (1) FR2794648B1 (fr)
RU (1) RU2283867C2 (fr)
ZA (1) ZA200110052B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130197612A1 (en) * 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
CN113943354B (zh) * 2021-10-11 2022-09-06 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种重组猫疱疹病毒gB蛋白抗原及其在抗体诊断和疫苗制备中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11504631A (ja) * 1995-04-25 1999-04-27 バイカル インコーポレイテッド Ｄｎａ／脂質複合体の単一バイアル製剤
AU2520197A (en) * 1996-04-29 1997-11-19 Riccardo Wittek Polynucleotide vaccine against canine distemper
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751227B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
AU1987197A (en) * 1997-03-10 1998-09-29 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purpose

Also Published As

Publication number Publication date
ATE499947T1 (de) 2011-03-15
ZA200110052B (en) 2002-10-10
DE60045685D1 (de) 2011-04-14
FR2794648A1 (fr) 2000-12-15
DK1185662T3 (da) 2011-06-20
RU2283867C2 (ru) 2006-09-20
ES2362347T3 (es) 2011-07-01

Similar Documents

Publication Publication Date Title
RU2319504C2 (ru) Вакцина собак против бешенства (варианты), способ вакцинации (варианты), набор для вакцинации (варианты)
UA77935C2 (uk) Композиція вакцини для свиней, спосіб та набір для вакцинації
JP2000516199A (ja) ウマの予防用ポリヌクレオチドワクチン製剤
Hu et al. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein
ATE272410T1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
PL189184B1 (pl) Kompozycja szczepionki polinukleotydowej dla bydła podawana drogą śródskórną, przenośna jednostka do szczepienia bydła oraz zastosowanie plazmidu do wytwarzania kompozycji szczepionki polinukleotydowej
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
CA2252375A1 (fr) Vaccination avec des acides nucleiques contre les infections parvovirales
HRP970383A2 (en) Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
Park et al. Cloning and further sequence analysis of the spike gene of attenuated porcine epidemic diarrhea virus DR13
CN101163494A (zh) 烷基糖苷增强的接种
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
RU2199584C2 (ru) Вектор (варианты), основанный на рекомбинантном дефектном вирусном геноме, и его применение для создания препаратов вакцин
FI3244920T3 (fi) Suu- ja sorkkatautirokote
JP2024001076A (ja) 狂犬病ウイルスワクチン
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
Seo et al. Protection of flounder against hirame rhabdovirus (HIRRV) with a DNA vaccine containing the glycoprotein gene
DE69233270D1 (de) Subeinheits-Impfstoff gegen Hundecoronavirus
FR2794648B1 (fr) Vaccins adn pour animaux de compagnie et de sport
Li et al. Protein encoded by ORF093 is an effective vaccine candidate for infectious spleen and kidney necrosis virus in Chinese perch Siniperca chuatsi
Baron et al. Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus
WO2001052888A3 (fr) Vaccins adn ameliores pour animaux de rente
MX2009013030A (es) Poxvirus de mapache que expresa genes de antigenos felinos.
ES2643031T3 (es) Vacuna contra garrapatas de Rhipicephalus
FR2724385B1 (fr) Vaccin de la peritonite infectieuse feline.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20